List of Primatene Mist drug patents

Primatene Mist is owned by Armstrong Pharms.

Primatene Mist contains Epinephrine.

Primatene Mist has a total of 1 drug patent out of which 0 drug patents have expired.

Primatene Mist was authorised for market use on 07 November, 2018.

Primatene Mist is available in aerosol, metered;inhalation dosage forms.

The generics of Primatene Mist are possible to be released after 26 January, 2026.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8367734 ARMSTRONG PHARMS Stable epinephrine suspension formulation with high inhalation delivery efficiency
Jan, 2026

(2 years from now)

Drugs and Companies using EPINEPHRINE ingredient

Market Authorisation Date: 07 November, 2018

Treatment: NA

Dosage: AEROSOL, METERED;INHALATION

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in